KalVista Pharmaceuticals, Inc. Contracts & Agreements
77 Contracts & Agreements
- Business Finance (34 contracts)
- Business Operations (5)
- Human Resources (25)
- Intellectual Property (1)
- Real Estate (6)
- Uncategorized (6)
- Securities Purchase Agreement by and between KalVista Pharmaceuticals, Inc. and DRI Healthcare Acquisitions LP, dated November 4, 2024 (Filed With SEC on November 4, 2024)
- Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, BofA Securities, Inc., TD Securities (USA) LLC and Stifel Nicolaus & Company, Incorporated,... (Filed With SEC on November 4, 2024)
- Executive Employment Agreement by and between the Registrant and Brian Piekos, dated September 9, 2024 (Filed With SEC on September 10, 2024)
- Amended and Restated Executive Employment Agreement between the Registrant and Benjamin L. Palleiko, dated September 9, 2024 (Filed With SEC on September 10, 2024)
- Amended and Restated Executive Employment Agreement between the Registrant and Paul K. Audhya, dated September 9, 2024 (Filed With SEC on September 10, 2024)
- Office Lease Agreement by and between the Registrant and OC 990 Corporate Center Associates, LLC dated July 22, 2024 (Filed With SEC on September 5, 2024)
- Separation Agreement by and between the Registrant and T. Andrew Crockett, dated March 6, 2024 (Filed With SEC on September 5, 2024)
- Amended and Restated Executive Employment Agreement between the Registrant and Benjamin L. Palleiko, dated March 7, 2024 (Filed With SEC on July 11, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 11, 2024)
- Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, Leerink Partners LLC, Stifel Nicolaus & Company, Incorporated, and Cantor Fitzgerald & Co.,... (Filed With SEC on February 16, 2024)
- Amended and Restated Executive Employment Agreement between KalVista Pharmaceuticals, Inc. and Benjamin L. Palleiko, dated June 8, 2023 (Filed With SEC on June 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on December 27, 2022)
- Subscription Agreement, dated as of December 23, 2022, by and among KalVista Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on December 27, 2022)
- Executive Employment Agreement by and between Registrant and Dr. Paul K. Audhya, MD (Filed With SEC on July 13, 2021)
- Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as Representatives of... (Filed With SEC on February 11, 2021)
- First Amendment of Lease, dated November 20, 2020, to the Office Lease Agreement by and between the Registrant and 55 Cambridge Parkway, LLC, dated May 19, 2017 (Filed With SEC on December 10, 2020)
- Description of the Registrants Securities (Filed With SEC on July 16, 2019)
- Amendment, dated June 26, 2019, to the Service Agreement dated November 1, 2015 by and between KalVista Pharmaceuticals Ltd and Dr. Christopher M. Yea (Filed With SEC on July 16, 2019)
- Executive Employment Agreement by and between Registrant and Michael Smith (Filed With SEC on July 16, 2019)
- Amended and Restated Executive Employment Agreement by and between Registrant and Edward Feener (Filed With SEC on July 16, 2019)
- Amended and Restated Executive Employment Agreement dated June 26, 2019, by and between the Registrant and Andreas Maetzel (Filed With SEC on July 16, 2019)
- Amended and Restated Employment Agreement between the Registrant and Benjamin L. Palleiko, dated June 26, 2019 (Filed With SEC on July 16, 2019)
- Amended and Restated Employment Agreement between the Registrant and T. Andrew Crockett, dated June 26, 2019 (Filed With SEC on July 16, 2019)
- Controlled Equity OfferingSM Sales Agreement, by and between KalVista and Cantor Fitzgerald dated March 29, 2019 (Filed With SEC on March 29, 2019)
- Equity Acceleration Letter dated March 11, 2019, by and between KalVista Pharmaceuticals Ltd, and Dr. Christopher M. Yea.# 31.1 Certification of Principal Executive Officer... (Filed With SEC on March 14, 2019)
- Amendment, dated January 31, 2019, to the Service Agreement dated November 1, 2015, by and between KalVista Pharmaceuticals Ltd and Dr. Christopher M. Yea (Filed With SEC on March 14, 2019)
- Underwriting Agreement by and among KalVista Pharmaceuticals, Inc. and Jefferies LLC, Stifel, Nicolaus & Company, Incorporated and Cantor Fitzgerald & Co., as Representatives of... (Filed With SEC on September 6, 2018)
- Form of Subscription Agreement (Filed With SEC on August 1, 2018)
- Service Agreement dated November 1, 2015, by and between KalVista Pharmaceuticals Ltd and Dr. Christopher M. Yea (Filed With SEC on July 30, 2018)
- Underlease by and between the Company and Wiltshire Council, dated April 30, 2018 (Filed With SEC on May 2, 2018)
- SEPARATION AGREEMENT (Filed With SEC on July 27, 2017)
- SEPARATION AGREEMENT (Filed With SEC on July 27, 2017)
- OFFICE LEASE AGREEMENT ___________________________________________ 55 CAMBRIDGE PARKWAY CAMBRIDGE, MA by and between 55 CAMBRIDGE PARKWAY, LLC, a Delaware limited liability... (Filed With SEC on July 27, 2017)
- KALVISTA PHARMACEUTICALS, INC. COMMON STOCK (par value$0.001 per share) AT-THE-MARKET SALES AGREEMENT (Filed With SEC on July 13, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2017)
- SHAREPURCHASE AGREEMENT BY AND AMONG CARBYLAN THERAPEUTICS, INC., THE SHAREHOLDERS OF KALVISTA PHARMACEUTICALS LTD., KALVISTA PHARMACEUTICALS LTD. AND THE SELLERREPRESENTATIVE... (Filed With SEC on November 23, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 23, 2016)
- INDEMNITY AGREEMENT (Filed With SEC on November 23, 2016)
- LEASE TERMINATION AGREEMENT (Filed With SEC on June 15, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 15, 2016)
- Form of Lock-up Agreement (Filed With SEC on June 15, 2016)
- SUPPORT AGREEMENT (Filed With SEC on June 15, 2016)
- SHAREPURCHASE AGREEMENT BY AND AMONG CARBYLAN THERAPEUTICS, INC., THE SHAREHOLDERS OF KALVISTA PHARMACEUTICALS LTD., KALVISTA PHARMACEUTICALS LTD. AND THE SELLERREPRESENTATIVE... (Filed With SEC on June 15, 2016)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on May 12, 2016)
- SEPARATION AGREEMENT (Filed With SEC on May 12, 2016)
- CARBYLAN THERAPEUTICS, INC. 2016 RETENTION BONUS PLAN (Filed With SEC on April 18, 2016)
- EXHIBIT A RELEASE AGREEMENT (Filed With SEC on April 18, 2016)
- LEASE by and between BMR-PACIFIC RESEARCH CENTER LP, aDelaware limited partnership and CARBYLAN THERAPEUTICS, INC., aDelaware corporation Table of Contents (Filed With SEC on July 14, 2015)
- CARBYLAN THERAPEUTICS, INC. ANNUAL INCENTIVE PLAN (Filed With SEC on April 6, 2015)
- CARBYLAN THERAPEUTICS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on April 6, 2015)
- CARBYLAN THERAPEUTICS, INC. (aDelaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2015)
- CARBYLAN THERAPEUTICS, INC. 2015 INCENTIVE PLAN (Filed With SEC on January 23, 2015)
- CARBYLAN THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on January 23, 2015)
- CARBYLAN THERAPEUTICS, INC. 2014 STOCK OPTION PLAN (Filed With SEC on December 29, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)
- CARBYLAN BIOSURGERY, INC. AMENDED AND RESTATED 2004 STOCK OPTION PLAN (as amended through December 19, 2012) (Filed With SEC on December 29, 2014)
- WARRANT TO PURCHASESTOCK (Filed With SEC on December 29, 2014)
- WARRANT TOPURCHASE STOCK (Filed With SEC on December 29, 2014)
- SECOND AMENDMENT TO WARRANT TO PURCHASE STOCK [October 26, 2011 Warrant] (Filed With SEC on December 29, 2014)
- FIRST AMENDMENT TO WARRANT TO PURCHASE STOCK [October 26, 2011 Warrant] (Filed With SEC on December 29, 2014)
- WARRANT TO PURCHASESTOCK (Filed With SEC on December 29, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on December 29, 2014)
- AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2014)
- TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on December 29, 2014)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)
- CARBYLAN THERAPEUTICS, INC. CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on December 29, 2014)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on December 29, 2014)
- Carbylan Therapeutics, Inc. Summary of Compensation Arrangement for Samuel Lynch (Filed With SEC on December 29, 2014)
- EXHIBIT A RELEASE AGREEMENT (Filed With SEC on December 29, 2014)
- CARBYLAN BIOSURGERY, INC. GEORGE Y. DANILOFF EMPLOYMENT AGREEMENT (Filed With SEC on December 29, 2014)
- EXHIBIT A RELEASE AGREEMENT (Filed With SEC on December 29, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT for David Renzi (Filed With SEC on December 29, 2014)
- COMMERCIAL LEASE (Filed With SEC on December 29, 2014)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 29, 2014)
